Effect of low-dose rituximab treatment on autoimmune nodopathy with anti-contactin 1 antibody
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.939062
Abstract: Background Autoimmune nodopathy with anti-contactin-1 (CNTN1) responds well to rituximab instead of traditional therapies. Although a low-dose rituximab regimen was administered to patients with other autoimmune diseases, such as myasthenia gravis and neuromyelitis optica spectrum… read more here.
Keywords: anti cntn1; dose rituximab; rituximab treatment; low dose ... See more keywords
Effect of monovalency on anti-contactin-1 IgG4
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1021513
Abstract: Introduction Autoimmune nodopathies (AN) have been diagnosed in a subset of patients fulfilling criteria for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) who display no or poor response to intravenous immunoglobulins. Biomarkers of AN are autoantibodies, mainly… read more here.
Keywords: anti cntn1; contactin; cntn1 igg4; cntn1 ... See more keywords